General Information of the Compound
| Compound ID |
CP0408250
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-[(2R)-2-[2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]ethyl]pyrrolidin-1-yl]sulfonylquinoline
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H32N4O4S
|
||||||||||||||||||
| Molecular Weight |
508.644
|
||||||||||||||||||
| Canonical SMILES |
O=S(=O)(N1CCC[C@@H]1CCN1CCN(CC1)c1cccc2OCCOc12)c1cccc2ncccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H32N4O4S/c32-36(33,26-10-1-7-23-22(26)6-3-12-28-23)31-13-4-5-21(31)11-14-29-15-17-30(18-16-29)24-8-2-9-25-27(24)35-20-19-34-25/h1-3,6-10,12,21H,4-5,11,13-20H2/t21-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GXHLJIAHGPNYES-OAQYLSRUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor